approached significanceP = .0707
Lymph node (LN) metastasis rates approached significance ( P = .0707), with BRCA1 BC showing fewer LN metastases (75%) than BRCA2 BC (53.8%).
Lymph node (LN) metastasis rates approached significance ( P = .0707), with BRCA1 BC showing fewer LN metastases (75%) than BRCA2 BC (53.8%).
Although this difference approaches statistical significance, it highlights a trend that may influence prognosis and treatment decisions.
Although this trend did not reach statistical significance, it suggests that BRCA2 BC may have a more invasive phenotype.
Notably, ER-positive BRCA tumors showed a trend toward higher recurrence.